loadpatents
name:-0.022508859634399
name:-0.0098907947540283
name:-0.0060398578643799
Sensfuss; Ulrich Patent Filings

Sensfuss; Ulrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sensfuss; Ulrich.The latest application filed is for "glucose sensitive insulin derivatives".

Company Profile
4.8.34
  • Sensfuss; Ulrich - Vanloese DK
  • Sensfuss; Ulrich - Copenhagen V DK
  • Sensfuss; Ulrich - Copenhagen DK
  • Sensfuss; Ulrich - Koebenhavn DK
  • Sensfuss; Ulrich - Koebenhavn V DK
  • Sensfuss; Ulrich - Bagsvaerd DK
  • Sensfuss; Ulrich - Kobenhavn DK
  • Sensfuss; Ulrich - Kobenhavn V DK
  • Sensfuss; Ulrich - Valby DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Glucose Sensitive Insulin Derivatives
App 20220184184 - Hoeg-Jensen; Thomas ;   et al.
2022-06-16
Novel Insulin Derivatives
App 20210024604 - Hoeg-Jensen; Thomas ;   et al.
2021-01-28
Insulin Derivatives
App 20200172593 - Hoeg-Jensen; Thomas ;   et al.
2020-06-04
GLP-1/glucagon receptor co-agonists for medical use
Grant 10,570,184 - Sensfuss , et al. Feb
2020-02-25
Novel Insulin Derivatives
App 20180371045 - Hoeg-Jensen; Thomas ;   et al.
2018-12-27
Stable GLP-1 based GLP-1/glucagon receptor co-agonists
Grant 9,988,430 - Reedtz-Runge , et al. June 5, 2
2018-06-05
Stable, Protracted Glp-1/glucagon Receptor Co-agonists For Medical Use
App 20180044394 - Sensfuss; Ulrich ;   et al.
2018-02-15
Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
Grant 9,751,927 - Sensfuss , et al. September 5, 2
2017-09-05
GLP-1/Glucagon Receptor Co-Agonists for Medical Use
App 20170101454 - Sensfuss; Ulrich ;   et al.
2017-04-13
Novel Peptides And Peptide Derivatives And Uses Thereof
App 20170008928 - Kruse; Thomas ;   et al.
2017-01-12
Stable, Protracted Glp-1/glucagon Receptor Co-agonists For Medical Use
App 20160355562 - Sensfuss; Ulrich ;   et al.
2016-12-08
Novel Glucagon Analogues
App 20160347812 - Lau; Jesper F. ;   et al.
2016-12-01
Glucagon analogues
Grant 9,486,506 - Lau , et al. November 8, 2
2016-11-08
Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
Grant 9,474,790 - Sensfuss , et al. October 25, 2
2016-10-25
Novel Insulin Derivatives
App 20160229902 - Hoeg-Jensen; Thomas ;   et al.
2016-08-11
Stable GLP-1 Based GLP-1/Glucagon Receptor Co-Agonists
App 20160102129 - Reedtz-Runge; Steffen ;   et al.
2016-04-14
Stable, Protracted Glp-1/glucagon Receptor Co-agonists For Medical Use
App 20150374794 - Sensfuss; Ulrich ;   et al.
2015-12-31
Novel Glucagon Analogues
App 20150368313 - Lau; Jesper F. ;   et al.
2015-12-24
Novel Glucagon Analogues
App 20150182594 - Lau; Jesper F. ;   et al.
2015-07-02
Novel Glucagon Analogues
App 20140031278 - Lau; Jesper F. ;   et al.
2014-01-30
Novel Glucagon Analogues
App 20130288958 - Lau; Jesper F. ;   et al.
2013-10-31
Glucagon analogues
Grant 8,541,368 - Lau , et al. September 24, 2
2013-09-24
Novel Glucagon Analogues
App 20130079278 - Lau; Jesper F. ;   et al.
2013-03-28
Peptides for Treatment of Obesity
App 20130012432 - Conde-Frieboes; Kilian Waldemar ;   et al.
2013-01-10
Insulin Derivatives
App 20120184487 - Hoeg-Jensen; Thomas ;   et al.
2012-07-19
Peptides for Treatment of Obesity
App 20120021973 - Lau; Jesper F. ;   et al.
2012-01-26
Novel peptides for use in the treatment of obesity
App 20110098213 - Sensfuss; Ulrich ;   et al.
2011-04-28
Peptides for Treatment of Obesity
App 20100173835 - Lau; Jesper ;   et al.
2010-07-08
Novel Peptides for Use in the Treatment of Obesity
App 20100056433 - Sensfuss; Ulrich
2010-03-04
Novel Peptides for Use in the Treatment of Obesity
App 20100016237 - Sensfuss; Ulrich ;   et al.
2010-01-21
Peptides for Use in the Treatment of Obesity
App 20100016238 - Sensfuss; Ulrich ;   et al.
2010-01-21
Novel Peptides for Use in the Treatment of Obesity
App 20090203581 - Sensfuss; Ulrich ;   et al.
2009-08-13
Peptides for use in treating obesity
Grant 7,541,430 - Sensfuss , et al. June 2, 2
2009-06-02
Melanocortin receptor agonists
Grant 7,517,854 - Conde-Frieboes , et al. April 14, 2
2009-04-14
Peptides for Use In Treating Obesity
App 20090088388 - Sensfuss; Ulrich ;   et al.
2009-04-02
Peptides for Use in the Treatment of Obesity
App 20080306008 - Sensfuss; Ulrich ;   et al.
2008-12-11
Novel Peptides for Use in the Treatment of Obesity
App 20080280820 - Sensfuss; Ulrich ;   et al.
2008-11-13
Novel Peptides for Use in the Treatment of Obesity
App 20080039387 - Sensfuss; Ulrich ;   et al.
2008-02-14
Peptides for use in treating obesity
App 20070244054 - Sensfuss; Ulrich ;   et al.
2007-10-18
Compounds and compositions for treating obesity
App 20070185128 - Conde-Frieboes; Kilian Waldemar ;   et al.
2007-08-09
Novel Melanocortin Receptor Agonists
App 20070027091 - Conde-Frieboes; Kilian Waldemar ;   et al.
2007-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed